Effects of p53 gene on drug resistance in human lung cancer cell lines

Chinese Journal of Lung Cancer

Volumn 11, Issue 2, 2008, Pages 157-164

  Tao, Hong ^a   Zhu, Yunzhong ^b   Wang, Hui ^b   Lai, Baitang ^b   Zhang, Chunyan ^b   Zhan, Xiuping ^b   Wang, Yue ^b   Yang, Xuehui ^b   Yue, Wentao ^b   Zhang, Hongtao ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Apoptosis; Cell cycle; Drug resistance; p53 gene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; COMPLEMENTARY DNA; FLUOROURACIL; GEMCITABINE; LIPOFECTIN; NAVELBINE; PACLITAXEL; PROTEIN P53;

ANTISENSE VECTOR; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL LINE; DNA SEQUENCE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; MOLECULAR CLONING; PLASMID; POLYMERASE CHAIN REACTION;

EID: 43649087022     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.02.001     Document Type: Article

References (18)

1. Sherr CJ. The pezcoller lecture: cancer cell cycles revisited. Cancer Res, 2000, 60(14): 3689-3695.
2. Mori S, Ito G, Usami N, et al. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Cancer, 2004, 100(8): 1673-82.
3. Wang H, Lai BT, Li JZ, et al. Study on the effects of p53 deletion and mutation on malignant phenotype of human lung cancer cell line. Chin J Lung Cancer, 2002, 5(4): 245-249.
4. Wang H, Lai BT, Li JZ, et al. Effects of p53 antisense RNA on malignant phenotype and sensitivity to cisplatin of human lung cancer cell line. Chin J Lung Cancer, 2002, 5(1): 1-5.
5. Zhang HW, Wang H, Lai BT, et al. Effects of exogenous wild-type p53 gene expression on sensitivity to chemotherapeutic agents in human lung cancer cell. Chin J Lung Cancer, 2000, 3(3): 166-169.
6. Wang H, Li JZ, Lai BT, et al. Inhibitory effect of p53 with deletion of c-terminal 356-393 amino acids on malignant phenotype of human lung cancer cell line. Chin J Oncol, 2003, 25(6): 527-530.
7. Robles AI, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene, 2002, 21(45): 6898-6907.
8. Hussain SP, Hofseth LJ, Harris CC. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer, 2001, 34(S2): S7-S15.
9. Lai SL, Perng RP, Hwang J. p53gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci, 2000, 7(1): 64-70.
10. 2/M transition by p53. Oncogene, 2001, 20(15): 1803-1815.
11. Yoon SS, Ahn KS, Kim SH, et al. In vitro establishment of cis-diammine-dichloroplatinum(II) resistant lung cancer cell line and modulation of apoptotic gene expression as a mechanism of resistant phenotype. Lung Cancer, 2001, 33(2-3): 221-228.
12. Quist SR, Wang-Gohrke S, Kohler T, et al. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status. Cancer Gene Ther, 2004, 11(8): 547-554.
13. Eisold S, Linnebacher M, Ryschich E, et al. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to status in pancreatic cancer cell lines. World J Gastroenterol, 2004, 1(24): 3583-3589.
14. Yoshikawa R, Kusunoki M, Yanagi H, et al. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res, 2001, 61(3): 1029-1037.
15. Lee BJ, Chon KM,, Kim YS, et al. Effects of Cisplatin, 5-Fluorouracil, and Radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line. Chemotherapy, 2005, 51(2-3): 103-110.
16. Galmarini CM, Clarke ML, Falette N, et al. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine. Int J Cancer, 2002, 97(4): 439-445.
17. Berrieman HK, Cawkwell L, O'Kane SL, et al. Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer. Oncol Rep, 2006, 15(1): 283-286.
18. Chang GC, Hsu SL, Tsai JR, et al. Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol, 2004, 502(3): 169-183.